- Home
- CNEY vs ACON Comparison
CNEY vs ACON Comparison
Compare CNEY & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNEY | ACON |
|---|---|---|
| Founded | 2009 | 2008 |
| Country | China | United States |
| Employees | N/A | 6 |
| Industry | Major Chemicals | Retail: Computer Software & Peripheral Equipment |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4M | 3.5M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNEY | ACON |
|---|---|---|
| Price | $0.69 | $3.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 455.9K | 133.1K |
| Earning Date | 02-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $87.22 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.12 | $2.34 |
| 52 Week High | $3.25 | $12.03 |
Technical Indicators
Market Signals| Indicator | CNEY | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 50.93 | 50.80 |
| Support Level | $0.54 | $3.00 |
| Resistance Level | $0.80 | $3.56 |
| Average True Range (ATR) | 0.12 | 0.30 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 40.25 | 41.24 |
Price Performance
Historical ComparisonAbout CNEY CN Energy Group Inc.
CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.